Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
5.02 USD | +1.83% | -3.83% | +51.20% |
05-16 | UBS Adjusts Rani Therapeutics Price Target to $8 From $4, Maintains Buy Rating | MT |
05-07 | HC Wainwright Adjusts Price Target on Rani Therapeutics Holdings to $13 From $12, Maintains Buy Rating | MT |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+51.20% | 130M | |
+11.99% | 116B | |
+12.95% | 106B | |
-9.04% | 23.89B | |
-1.69% | 21.58B | |
-10.60% | 18.96B | |
-41.25% | 16.96B | |
-14.49% | 16.33B | |
+6.70% | 14.14B | |
+31.09% | 12.02B |
- Stock Market
- Equities
- RANI Stock
- News Rani Therapeutics Holdings, Inc.
- Insider Sell: Rani Therapeutics Holdings